AccuLine is developing CORA, an accurate, quick, and non-invasive assessment for early detection of heart attacks
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Petah Tiqva
State: HaMerkaz
Zip:
Country: Israel
AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide. AccuLine is developing CORA—a smart, accurate, and easy to use exam for the early detection of coronary artery disease. The clinically validated CORA evaluates a patient&s;s risk of having coronary artery disease through advanced analysis and detection of two newly discovered biomarkers in the heart’s electrical activity. CORA’s early detection will assist in the prevention of sudden cardiac deaths, while lowering costs of cardiovascular related illness.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Pre Seed Round | 1 | $300k |
Maccabi Fund Maccabi Fund |
3/2022 | Grant | 2 | $1M |
eHealth Ventures Israel Innovation Authority eHealth Ventures Israel Innovation Authority |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|